Saturday, December 18, 2004

Pfizer Finds Celebrex Heart Attack Risk

"Pfizer Inc. said it has found an increased risk of heart attacks with patients taking its top-selling painkiller Celebrex, a drug that is in the same class as Vioxx, but has no plans to remove it from the market."

I knew this was coming, i just never saw a chance to make any money by placing a bet with anyone.

I wonder if you are a major drug company if you can fund a study for the competitors drugs. For example, could Pfizer have funded a study on Merk's products? If it went through a school, proxy, or the fda, it could probably gain acceptance. Would it be better to bring you opponent down instead of bringing yourself up?


No comments: